Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

RLMD Relmada Therapeutics Inc

2,99

-0,01 (-0,33%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:08:23

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Relmada Therapeutics Charts.

News Relmada Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat
Dienstag 19 März 2024 (3 Monate vor) • IH Market News

Form 144 - Report of proposed sale of securities
Dienstag 20 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Relmada Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen